|
Novartis licenses Ophthotech eye drug in $1bn deal
PMLiVE Fovista is claimed to be the closest to market of all anti-PDGF (platelet derived growth factor) drugs in development and could be a first-in-class therapy for the wet form of age-related macular degeneration (AMD), a leading cause of acquired blindness. |
Source: Wet Macular Degeneration News From Google News
Zennie Abraham | Zennie Abraham or “Zennie62” is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.